Resilience in Older Adults with Leukemia Receiving Initial Treatment: The ROAR-1 Study
Categories (click each to see list of all clinical trials associated with that category): Leukemia/MDS/MPD (ONC)
Current Status: Open
Phase: IV (Cancer Control)
Principal Investigator: Bhatt, Vijaya
Contact Information:
Marnee Strege
+1 402-559-8155
marnee.strege@unmc.edu
Summary
Primary objectives
1. Determine the longitudinal attention and executive function of older adults with AML before and after
venetoclax-based treatment, as compared to age-, sex-, and education-matched non-cancer controls.
2. Determine longitudinal changes in functional independence and HRQOL in older adults with AML versus controls,
and examine their associations with longitudinal changes in attention and executive function.
Secondary objectives
3. Measure longitudinal changes in the activity of brain networks of older adults with AML before and after
venetoclax-based treatment, as compared to controls.